Search - tctmd.com

Displaying 121 - 140 of 295

Sort: Relevancy | Date

Presentation CIT 2014

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Presenter: Yong Huo

March 22, 2014

News Daily News

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

L.A. McKeown

February 17, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Industry News

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

October 30, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

Presentation TCT 2013

Preclinical assessment of sirolimus eluting stent with prohealing polymer: 6 months follow-up in porcine model

Presenter: Yizhe Wu

October 29, 2013

Presentation TCT 2013

TCT-39. 12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial

Presenter: Ricardo Costa

October 29, 2013

Presentation TCT 2013

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Presenter: Robert Gil

October 29, 2013

Presentation TCT 2013

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

Presenter: Yelin Zhao

October 29, 2013

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

Presentation TCT 2013

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Presenter: Laura Mauri

October 28, 2013

Presentation TCT 2013

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Presenter: Michael Haude

October 27, 2013

Presentation TCT 2013

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

Presenter: Ricardo Costa

October 27, 2013

Presentation TCT 2013

MiStent: 2-year Randomized Trial Results from a Sirolimus-eluting Stent with a Bioabsorbable Coating

Presenter: John Ormiston

October 27, 2013

Presentation TCT 2013

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

Presenter: Bo Xu

October 27, 2013

News Industry News

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

October 22, 2013

Advertisement

A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery Disease

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

Stent Malapposition Frequent, But Without Clinical Consequences

Second-Generation DES the Better Choice for STEMI Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

Preclinical assessment of sirolimus eluting stent with prohealing polymer: 6 months follow-up in porcine model

TCT-39. 12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

MiStent SES Shown to be Unique in Clinical Setting

PROTECT: Four-Year Results from a Prospective, Randomized Trial of Sirolimus-Eluting Stents and Zotarolimus-Eluting Stents

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results

MiStent: 2-year Randomized Trial Results from a Sirolimus-eluting Stent with a Bioabsorbable Coating

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content